SC 13D

Company

IOVANCE BIOTHERAPEUTICS, INC.

Filed

June 13, 2016

Accession Number

0001104659-16-126891

A Schedule 13D is filed when an investor acquires more than 5% of a company's shares with an intent to influence control. Learn more about SC 13D filings →